SueKillionCammarataMD
Pulmonology • Chicago, ILCritical Care Medicine, Sleep Medicine
Senior Clinical Subject Matter Expert to Biomedical Advanced Research and Development Authority (BARDA)
Dr. Cammarata is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Chicago
Chicago, IL 60654
Education & Training
Henry Ford Health/Henry Ford HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1986 - 1989
Michigan State University College of Human MedicineClass of 1986
Certifications & Licensure
MI State Medical License 1987 - 2027- American Board of Internal Medicine Internal Medicine
- American Academy of Sleep MedicineSleep Medicine
Clinical Trials
- Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Start of enrollment: 2013 Apr 01
- Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Start of enrollment: 2014 May 01
- Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea Start of enrollment: 2014 Jan 23
- Join now to see all
Publications & Presentations
PubMed
- 31 citationsA Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP).Juan Pablo Horcajada, Robert A. Salata, Rodolfo Álvarez-Sala, Floarea Mimi Nitu, Laura Lawrence
Open Forum Infectious Diseases. 2019-12-05 - 47 citationsEvidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.Anita Das, Stephanie S. Cush, Aaron Dane, Michele Wible, Roger Echols
The Journal of Infectious Diseases. 2019-04-19 - 60 citationsIn Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 S...Sandra P. McCurdy, Laura Lawrence, Megan Quintas, Leah N. Woosley, Robert K. Flamm
Antimicrobial Agents and Chemotherapy. 2017-09-01
Press Mentions
Why This FDA Approval for Pneumonia Treatment Is so HugeJune 19th, 2019
Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual MeetingMay 7th, 2019- Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)April 8th, 2019
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
- Fellow
- Member
External Links
- BARDAhttp://Www.medicalcountermeasures.gov
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
